Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 482
Immune Disorders Drugs 201
Drug Discovery 169
Cardiovascular Drugs 159
Infectious Diseases Drugs 138
Biopharmaceuticals 133
Clinical Trials 126
Endocrine and Metabolic Disorders Drugs 110
Central Nervous System Drugs 100
Pharmaceuticals 95
Musculoskeletal Disorders Drugs 94
Leukemia Drugs 84
Hematological Drugs 83
Liver and Kidney Disorders Drugs 81
Lymphoma Drugs 62
Dermatological Drugs 55
Diabetes Drugs 54
Skin Cancer Drugs 51
Brain Cancer Drugs 45
Respiratory Drugs 44
Gastrointestinal Drugs 41
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Pharmaceutical Intermediates 38
Drug Delivery 37
Immunosuppressive Drugs 34
Pharmaceutical Manufacturing 33
Infusions and Injectables 30
Liver Cancer Drugs 28
Bladder Cancer Drugs 25
Analgesics 25
Drugs by Therapeutic Area 24
Antibiotics 23
Kidney Cancer Drugs 22
Colon Cancer Drugs 20
HIV/AIDS Drugs 20
Prostate Cancer Drugs 18
Pancreatic Cancer Drugs 18
Schizophrenia Drugs 18
Urological Disorders Drugs 17
Sexual and Reproductive Health Drugs 15
Ovarian Cancer Drugs 14
Cervical Cancer Drugs 14
Breast Cancer Drugs 13
Cancer Vaccines 13
Thyroid Cancer Drugs 12
Psoriasis Drugs 12
Generic Drugs 10
Biosimilars and Biosuperiors 10
Over the Counter (OTC) Drugs 9
Vaccines 9
Transdermal and Transmucosal Drug Delivery 8
Anti-Obesity Drugs 8
Optical Disorders Drugs 7
Alzheimer's Disease Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Anxiety Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



276 reviews

2,463 Results (Page 24 of 124)
- Relevance
  Sort by

Drug Delivery Market - Forecasts from 2024 to 2029

 Report
April 2024
132 Pages
Global

From

€3901EUR$3,950USD£3,246GBP

Immunosuppressants Global Market Report 2024

 Report
February 2024
250 Pages
Global

From

€4938EUR$5,000USD£4,109GBP

Hematological Malignancies Emerging Therapeutics Market - A Global and Regional Analysis: Focus on Therapeutic Type (Marketed), Potential Pipeline Products, Indication, and Region - Analysis and Forecast, 2021-2031

 Report
February 2022
258 Pages
Global

From

€5185EUR$5,250USD£4,314GBP

Hepatocellular Carcinoma Drugs Global Market Report 2024

 Report
January 2024
200 Pages
Global

From

€4938EUR$5,000USD£4,109GBP

Bladder Cancer Therapeutics and Diagnostics Market - Growth, Trends, and Forecast (2020 - 2025)

 Report
August 2020
115 Pages
Global

From

€4198EUR$4,250USD£3,492GBP

NEED HELP FINDING THE RIGHT PRODUCT? Craig will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Polycystic Kidney Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
July 2022
109 Pages
Global

From

€1975EUR$2,000USD£1,643GBP

Corticosteroids Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4938EUR$5,000USD£4,109GBP

Plaque Psoriasis - Pipeline Insight, 2024

 Clinical Trials
April 2024
240 Pages
Global

From

€1728EUR$1,750USD£1,438GBP

€2469EUR$2,500USD£2,054GBP

Edema Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II), Participant (Pediatrics, Adults), Study Design (Interventional Trials, Observational Trials), Type (Systemic Edema, Localized Edema), Region, and Segment Forecasts, 2023-2030

 Report
November 2023
175 Pages
Global

From

€5877EUR$5,950USD£4,889GBP

Antiviral Drugs Market by Mechanism of Action, Target Indication, Type of Drug Target, Type of Therapy and Key Geographies: Industry Trends and Global Forecasts, 2022-2035

 Report
September 2022
194 Pages
Global

From

€4740EUR$4,799USD£3,944GBP

Antithrombotic Drugs Market 2023-2027

 Report
May 2023
156 Pages
Global

From

€2469EUR$2,500USD£2,054GBP

Schizophrenia Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

 Report
October 2022
113 Pages
Global

From

€4691EUR$4,750USD£3,903GBP

Non-Alcoholic Steatohepatitis (NASH) - Pipeline Insight, 2024

 Clinical Trials
April 2024
240 Pages
Global

From

€2074EUR$2,100USD£1,726GBP

€2963EUR$3,000USD£2,465GBP

Pharmaceutical Market Size, Share & Trends Analysis Report by Molecule Type, Product, Type, Disease, Formulation, Age Group, Route Of Administration, End Market, Region, and Segment Forecasts, 2023-2030

 Report
December 2023
250 Pages
Global

From

€5877EUR$5,950USD£4,889GBP

Global Lung Cancer Drugs Market - Drivers, Restraints, Opportunities, Trends, and Forecast up to 2025

 Report
April 2019
93 Pages
Global

From

€2728EUR$2,763USD£2,270GBP

€3210EUR$3,250USD£2,671GBP

Schizophrenia Drugs Market By Therapeutic Class, By Treatment, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031

 Report
July 2022
220 Pages
Global

From

€3526EUR$3,570USD£2,934GBP

Global Non Small-Cell Lung Cancer Market By Type, By Treatment Type, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031

 Report
October 2022
262 Pages
Global

From

€3526EUR$3,570USD£2,934GBP

Atopic Dermatitis Drugs Market by Drug Class, Route of Administration - Global Forecast 2025-2030

 Report
October 2024
196 Pages
Global

From

€3501EUR$3,545USD£2,913GBP

€3890EUR$3,939USD£3,237GBP

Sickle Cell Disease Treatment Market Analysis & Forecast to 2024-2034

 Report
January 2024
200 Pages
Global

From

€4099EUR$4,150USD£3,410GBP

Hepatocellular Carcinoma - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€5496EUR$5,565USD£4,573GBP

€7852EUR$7,950USD£6,533GBP

2,463 Results (Page 24 of 124)
- 1
- 22
- 23
- 24
- 25
- 26

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.